Exposure to myelotoxic agents and myelodysplasia: Case-control study and correlation with clinicobiological findings

British Journal of Haematology

Volumn 103, Issue 1, 1998, Pages 189-197

  Rigolin, Gian Matteo ^a   Cuneo, Antonio ^a,b   Roberti, Maria Grazia ^a   Bardi, Antonella ^a   Bigoni, Renato ^a   Piva, Nadia ^a   Minotto, Claudia ^a   Agostini, Paola ^a   De Angeli, Cristiano ^a   Del Senno, Laura ^a   Spanedda, Romedio ^a   Castoldi, Gianluigi ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Haematology Section   (Italy)

Author keywords

Case control study; Cytogenetics; Mutagenic agents; Myelodysplastic syndromes; Survival

Indexed keywords

MUTAGENIC AGENT; SOLVENT;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CONTROLLED STUDY; CYTOGENETICS; DOSE RESPONSE; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; OCCUPATIONAL EXPOSURE; PEST CONTROL; PRIORITY JOURNAL; REFRACTORY ANEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOGENS, ENVIRONMENTAL; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; HUMANS; KARYOTYPING; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OCCUPATIONAL EXPOSURE; PESTICIDES; SOLVENTS; SURVIVAL RATE; WASHINGTON;

EID: 7844238985     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00963.x     Document Type: Article

References (52)

1. Aul, C., Gattermann, N. & Schneider, W. (1992) Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. British Journal of Haematology, 82, 358-367.
2. Becher, R., Carbonell, F. & Bartram, C.R. (1990) Isochromosome 17q in Ph1-negative leukemia: a clinical, cytogenetic and molecular study. Blood, 75, 1679-1683.
3. Bennett, J.M. Catovsky, D., Daniel, M.T., Flandrin, G., Galton, G., Gralnick, H. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
4. Bernasconi, P., Alessandrino, E.P., Boni, M., Bonfichi, M., Morra, E., Lazzarino, M., Campagnoli, C. & Astori, C. (1994) Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival. American Journal of Hematology, 46, 270-277.
5. Boultwood, J., Lewis, S. & Wainscoat, J.S. (1994) The 5q-syndrome. Blood, 84, 3253-3260.
6. Brown, L.M., Blair, A., Gibson, R., Everett, G.D., Cantor, K.P., Schuman, L.M., Burmeister, L.E., Van Lier, S.F. & Dick, F. (1990) Pesticide exposure and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Research, 50, 6585-6591.
7. Castoldi, G. & Cuneo, A. (1996) Special cytological subtypes of acute myeloid leukaemias and myelodysplastic syndromes. Baillière's Clinical Haematology, 9, 19-33.
8. Crane, M.M. & Keating, M.J. (1991) Exposure histories in acute nonlymphocytic leukemia patients with a prior preleukemic condition. Cancer, 67, 2211-2214.
9. Cuneo, A., Fagioli, F., Pazzi, I., Tallarico, A., Previati, R., Piva, N., Carli, M.G., Balboni, M. & Castoldi, G. (1992) Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents. Leukemia Research, 16, 789-796.
10. Cunningham, I., MacCallum, S.J., Nicholls, M.D., Byth, K., Hewson, J.W., Arnold, B., Motum, P.I., Mulligan, S.P. & Crane, G.G. (1995) The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institution. British Journal of Haematology, 90, 602-608.
11. Fagioli, F., Cuneo, A., Piva, N., Carli, M.G., Previati, R., Balboni, M., Tomasi, P., Cariani, D., Scapoli, G. & Castoldi, G. (1992) Distinct cytogenetic and clinico-pathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents. Cancer, 70, 77-85.
12. Farrow, A., Jacobs, A. & West, R.R. (1989) Myelodysplasia, chemical exposure and other environmental factors. Leukemia, 3, 33-35.
13. Fenaux, P., Morel, P. & Lai, J.L. (1996) Cytogenetics of myelodysplastic syndromes. Seminars in Hermatology, 33, 127-138.
14. Fourth International Workshop on Chromosomes in Leukemia, 1982 (1984) The correlation of karyotype and occupational exposure to potential mutagenic/carcinogenic agents in acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics, 11, 326-331.
15. Gallagher, A., Darley, R.L. & Padua, R.A. (1997) The molecular basis of myelodysplastic syndromes. Haematologica, 82, 191-204.
16. Goldberg, H., Lusk, H., Moore, J., Nowell, P.C. & Besa, E.C. (1990) Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease. Cancer Research, 50, 6876-6881.
17. Golomb, H.M., Alimena, G., Rowley, J.D., Vardiman, J.W., Testa, J.R. & Sovik, C. (1982) Correlation of occupation and karyotype in adults with acute non-lymphocytic leukemia. Blood, 60, 404-411.
18. Greaves, M.F. (1997) Aetiology of acute leukaemia. Lancet, 349, 344-349.
19. Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett., J. (1997) International scoring system for evaluating prognosis in myclodysplastic syndromes. Blood, 89, 2079-2088.
20. Hawkins, J.M., Moorman, A.V., Hoffbrand, V., Martineau, M., Wright, F.S., Mehta, A.B., Prentice, G. & Secker-Walker, L.M. (1994) Association of 17p loss with late-stage or refractory disease in hematologic malignancy. Cancer Genetics and Cytogenetics, 77, 134-145.
21. ISCN (1995) An International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman). Karger, Basel.
22. Jacobs, A. (1989) Benzene and leukaemia. British Journal of Haematology, 72, 119-121.
23. Jacobs, A., Geary, C. & Osman, J. (1995) Haematological disorders and occupational hazards: a British Society for Haematology/ Health and Safety Executive study. British Journal of Haematology, 84, 555-557.
24. Johnson, E. & Cotter, F.E. (1997) Monosomy 7 and 7q-associated with myeloid malignancy. Blood Reviews, 11, 46-55.
25. Kaneko, H., Misawa, S., Horiike, S., Nakai, H. & Kashima, K. (1995) TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities. Blood, 85, 2189-2195.
26. Kouides, P.A. & Bennett, J.M. (1995) Myelodysplastic syndromes. Clinical Oncology (ed. by M. D. Abeloff, J. O. Armitage, A. S. Lichter and J. e. Niederhube), pp. 1977-1998. Churchill Livingstone, New York.
27. Lai, J.L., Preudhomme, C., Zandecki, M., Flactif, M., Vanrumbeke, M., Wattel, K. & Fenaux, P. (1995) Myelodysplastic syndromes and acute myeloid leukemia with 17p deletions: an entity characterised by specific dysgranulopoieis and a high incidence of P53 mutations. Leukemia, 9, 370-381.
28. Lambertenghi-Delilers, G., Orazi, A., Luksch, R., Annaloro, C. & Soligo, D. (1991) Myelodysplastic syndrome with increased marrow librosis: a distinct clinico-pathological entity. British Journal of Haematology, 78, 161-166.
29. Le Beau, M.M., Albain, K.S., Larson, R.A., Vardiman, J.W., Davis, E.M., Blough, R.R., Golomb, H.M. & Rowley, J.D. (1986) Clinical and cytogenetic correlations in 65 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosome no. 5 and 7. Journal of Clinical Oncology, 4, 325-345.
30. Lichtman, M.A. & Brennan, J.K. (1995) Myelodysplastic disorders. Williams Hematology (ed. by E. Beutler, M. A. Lichtman, B. S. Coller and T. J. Kipps), pp. 257-275. McGraw-Hill, New York.
31. Maschek, H., Gutzmer, R., Choritz, H. & Georgii, A. (1995) Comparison of scoring systems in primary myelodysplastic syndromes. American Journal of Hematology, 70, 301-308.
32. Matthews, D.E. & Farewell, V.T. (1996) Using and Understanding Medical Statistics, 3rd revised edn. Karger, Basel.
33. Mecucci, C., Van Orshoven, A., Boogaerts, M., Michaux, J.L. & Van Den Berghe, H. (1989) Characterization of deletion of chromosome 7 short arm occurring as primary karyotypic anomaly in acute myeloid leukaemia. British Journal of Haematology, 71, 13-22.
34. Pasqualetti, P., Festuccia, V., Acitelli, P., Collacciani, A., Giusti, A. & Casale, R. (1997) Tobacco smoking and risk of haematological malignancies in adults: a case-control study. British Journal of Haematology, 97, 659-662.
35. Pedersen, B. (1997) MDS and AML with trisomy 8 as sole chromosome aberration show different sex ratios and prognostic profiles: a study of 115 published cases. American Journal of Hematology, 56, 224-229.
36. Pedersen-Bjergaard, J., Philip, P., Larsen, S.O., Jensen, G. & Byrsting, K. (1990) Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood, 76, 1083-1091.
37. Pedersen-Bjergaard, J. & Rowley, J.D. (1994) The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood, 83, 2780-2786.
38. Pierre, R., Catovsky, D., Mufti, G., Swansbury, G., Mecucci, C., Dewald, G.W., Ruutu, T., Van Den Berghe, H., Rowley, J.D., Mitelman, P., Reeves, B.R., Alimena, G., Garson, O.M., Lawler, S.D. & de la Chapelle, A. (1989) Clinical-cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genetics and Cytogenetics, 40, 149-161.
39. Rigolin, G.M., Cuneo, A., Roberti, M.G., Bardi, A. & Castoldi, G. (1997) Myelodysplastic syndromes with monotytic component: hematologic and cytogenetic characterization. Haematologica, 82, 25-30.
40. Rinsky, R., Smith, A.B., Horning, R., Fillon, T., Young, R., Okun, A. & Landrigan, P. (1987) Benzene and leukemia: an epidemiological risk assessment. New England Journal of Medicine, 316, 1044-1056.
41. Rodrigues Perreira Velloso, H., Michaux, L., Ferrant, A., Hernandez, J.M., Meeus, P., Dierlamm, J., Criel, A., Louwagie, A., Verhoef, G., Boogaerts, M., Michaux, J.L., Bosly, A., Mecucci, C. & Van den Berghe, H. (1996) Deletions of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis. British Journal of Haematology, 92, 574-581.
42. Strickland, P.T. & Kensler, T.W. (1995) Chemicals and physical agents in our environment. Clinical Oncology (ed. by M. D. Abeloff, J. O. Armitage, A. S. Lichter and J. E. Niederhuber), pp. 151-166. Churchill Livingstone, New York.
43. Swanson, G.M. (1988) Cancer prevention in the workplace and natural environment: a review of etiology, research design and methods of risk reduction. Cancer, 62, 1725-1746.
44. Toyama, K., Ohyashiki, K. & Koshida, Y. (1995) Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia, 7, 499-508.
45. Tuzuner, N., Cox, C., Rowe, J.M., Watrous, D. & Bennett, J.M. (1995) Hypocellular myelodysplastic syndromes (MDS): new proposals. British Journal of Haematology, 91, 612-617.
46. Van Den Berghe, H. & Michaux, L. (1997) 5q-, twenty-five years later: a synopsis. Cancer Genetics and Cytogenetics, 94, 1-7.
47. Wattel, E., Lai, J.L., Hebbar, M., Preudhomme, C., Grahek, D., Morel, P., Bauters, F. & Feanux, P. (1993) De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features. Leukemia Research, 17, 921-926.
48. West, R.R., Stafford, D.A., Farrow, A. & Jacobs, A. (1995) Occupational and environmental exposures and myelodysplasia: a case-control study. Leukemia Research, 19, 127-139.
49. Whang-Peng, J., Young, R.C., Lee, E.C., Longo, D.L., Schecter, G.P. & DeVita, V.T. (1988) Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood, 71, 403-414.
50. White, A.D., Culligan, D.J., Hoy, T.G. & Jacobs, A. (1992) Extended cytogenetic follow-up of patients with myelodysplastic syndrome (MDS). British Journal of Haematology, 81, 499-502.
51. Wong, O. (1990) A cohort mortality study and a case-control study of workers potentially exposed to styrene in the reinforced plastics and composites industries. British Journal of Industrial Medicine, 47, 753-761.
52. Zahm, S.H. & Blair, A. (1992) Pesticides and non-Hodgkin lymphoma. Cancer Research, 52, (Suppl. 1), 5485-5488.